MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 16, Issue 12, 2002, Pages 1680-1682

  Romerio, Fabio ^a   Zella, Davide ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA2B INTERFERON; DRUG DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; HYPERICIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PERYLENE; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL DIVISION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TIME;

CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DIVISION; DRUG SYNERGISM; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; INTERFERON ALFA-2B; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PERYLENE; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0036777854     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0120fje     Document Type: Article

References (0)